NEWBURY, England--(BUSINESS WIRE)--Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low rates of structural valve deterioration (SVD) in bioprosthetic aortic ...
Oksana Tehlivets from the Institute of Molecular Biosciences at the University of Graz, Gerhard A. Holzapfel and Francesca Bogoni from the Institute of Biomechanics at Graz University of Technology ...
LOS ANGELES -- Survival outcomes favored mechanical valves for isolated surgical aortic valve replacement (SAVR) for people until age 60, after which a tissue valve may start to have an advantage, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results